Health Archive » September, 2019

Health - September, 2019

347 articles

• FDA, DEA Collaborate On Warnings Over Opioid Sales
• DOJ Wins Bids To End FCA Suits Targeting Eli Lilly, Bayer
• Gov't Mulls Changes To Abortion Policy For Migrant Teens
• Health Insurer Slips ERISA Claim Over Liposuction Coverage
• $4.5M Deal In Hospital Pension Dispute Gets Judge's Final OK
• NJ Doctor Can't Escape Jury Verdict In Eye Surgery Suit
• Glumetza Makers Slapped With 2 New Suits Over Price Hikes
• Purdue's $38M Bonus Plan In Ch. 11 Draws Watchdog's Ire
• Crypto Firm Accuses Telemed Startup Of Investment Scam
• FTC Taking A Closer Look At $63B AbbVie-Allergan Deal
• Michigan E-Cig Ban Withstands Early Challenge
• Opioid Negotiation Class May Be Organic Procedure Evolution
• 'Cyber Hunt' Bill Targeting Ransomware Clears Senate
• Ex-Sanofi Employee Says Doctor Program Was For Kickbacks
• True Wellness Requires A Deeper Look At Atty Profession
• UnitedHealthcare Dodges Bulk Of Wilderness Therapy Suit
• 35 Charged In $2.1B Telehealth Gene Test Fraud
• Calif. Group Seeks To Raise State's Med Mal Damages Cap
• Antitrust Case Against IQVIA Will Join Larger Fight In NJ
• New Bills Focus On Native American Health Care Access
• J&J Hit With $40M Verdict In Calif. Talc Cancer Trial
• Sanofi Beats First Bellwether In Chemo Drug Hair Loss MDL
• Washington To Ban Flavored Vape Products, Including THC
• Eye on ERISA: Q&A With McDermott's Ted Becker
• Tribe's $1.1M Request Granted In IHS Clinic Funding Suit
• Keep Med Supply Pricing Suit Buried, Becton Urges 7th Circ.
• 8 Best Practices For Handling ERISA Benefit Claims
• Court Cites Autodialer Disputes In Rejecting $6M TCPA Deal
• Dispensary Chain Ends 2-State License Fight With Pot Shop
• Law360's Tort Report: Personal Injury & Med Mal News In Brief
• Robbins Geller To Lead Reckitt Stock-Drop Suit
• Pursuing Wellness
• Mylan Inks $30M SEC Deal After Not Disclosing EpiPen Probe
• Minn. AG Defends Insulin Suit Against Sanofi, Novo, Lilly
• J&J Launches Appeal Of $572M Okla. Opioid Judgment
• Avanir To Pay $108M Over Nuedexta Drug Kickback Scheme
• Vaping Industry Group Sues To Block NY's Flavored E-Cig Ban
• 'Negotiation Class' In Opioid MDL Is Unlawful, 6th Circ. Told
• Mass. Wants New Ruling In ACA Birth Control Coverage Suit
• Gov't Backs SmileDirect In Ga. Dental Board Members' Appeal
• Dialysis Co. Wants 5th Circ. Redo In Tenn. Benefits Law Suit
• Pa. High Court Reinstates $2.4M Broken Leg Verdict
• HHS Properly Handled New Liver Transplant Rule: 11th Circ.
• Verdict Against Dentist Nixed In Suit Over Inhaled Drill Bit
• Certification Board Escapes Doctors' Antitrust Suit
• Two Essure Users Fight Uphill To Keep Injury Claims Alive
• What To Do When A Private Equity Firm Wants Your Business
• Md. Judge Cuts Jury's $229M Verdict In Birth Injury Suit
• Rival Can't Shake AngioDynamics' $145M Racketeering Suit
• Centene, WellCare Sell Medicaid Plans Amid $17B Deal Review
• How BigLaw Is Adapting To Plaintiff-Side Litigation
• Calif. Tells Judge J&J Must Pay $800M For Mesh Marketing
• Opioid MDL Judge Won't Withdraw Over Bias Charge
• Battle Lines Drawn For Opioid MDL's Bellwether Trial
• Calif. Doc Keeps Trial Win In Unwanted Knee Surgery Suit
• Calif. Court Revives Botched Liposuction Suit
• La. Court Affirms Hospital's Trial Win In Patient Death Suit
• Judge Blocks Talk Of J&J Mesh Sales Revenue In Calif. Trial
• Gov't Claimants Want Insys Bankruptcy Converted To Ch. 7
• DOJ Targets Telehealth Fraud Tied To Genetic Testing
• NantHealth Urges Chancery To Boot Research Deal Suit
• FDA Acting Head Says E-Cig Policy To Be Final Soon
• Trident Inks $8.5M Deal To End Kickback Allegations
• Dems Defend Drug Price Negotiation Bill Against GOP Outcry
• Del. Justices Warned Not To Upend Fabric Of Disclosure Law
• Pursuing Wellness: A Focus On Firm Holistic Health Training
• THC Vaping Health Issues Warrant Safety Standards
• Lieff Cabraser, Elliot Morgan Nab $21M Of No-Poach Deal
• Pa. Judge Scolds Gov't For Delays On UnitedHealth FCA Suit
• Hogan Lovells Adds Corporate Pro To Life Sciences Group
• Judging A Book
• Opioid MDL Judge Rejects J&J's Attack On Trial Format
• Senate Panel OKs $35.8B Bill For DOI, EPA, Tribal Programs
• House Dems, Republicans Split On Cause Of Vaping Deaths
• Ex-PetMed Exec Cuts Deal With SEC In Insider Trading Suit
• Want Your Rival's Funder Info? Be Specific, Or Don't Bother
• Texas Nurses Must Face Suit Over Child's Brain Damage
• Courtroom Tech Experts In High Demand For Injury Trials
• Kirkland Steers Enhanced Healthcare Partners' $300M Fund
• Doctor Can't Shake Convictions In $100M Referral Scheme
• DOJ Charges More Doctors In Appalachia Opioid Sweep
• Lobbyist Says Cancer Center Owes $11M Despite Ch. 11 Rule
• Cardinal Health Board Wants Opioid Derivative Suit Axed
• Mass. Vape Ban Draws Ire Of State Pot Commissioner
• Walgreens Must Face Fraud Claims In Stock-Drop Suit Redo
• J&J Unit Escapes Suit Over Breast Implant Warnings
• Judge Jackson Reviews 'When Should Law Forgive?'
• Levi & Korsinsky, Bernstein Vie For Lead In Karyopharm Suits
• Hospital System Accused Of Stingy Mental Health Coverage
• Ex-FDA Director Says Agency Found J&J's Mesh Labels OK
• HHS Can Force Drug Prices In TV Ads, DC Circ. Hears
• Mass. Hospital Can't Nix Arbitrator's Reinstatement Of Nurse
• Cannabis Atty Wants To Take Legalization Fight To Congress
• Court OKs $50M Philly Hospital Sale To Tower Health, Drexel
• Maryland Conversion Therapy Ban Survives Free Speech Suit
• Privilege Can't Shield Divorce Files In Widow's Med Mal Case
• Gov't Wins Trial In Suit Over Texas VA Surgery
• NH AG Raises Red Flags Over Planned Hospital Merger
• Loestrin Judge Assigns Antitrust Homework Before Hearing
• Fla. Blue Cross Broker Exclusivity Gets Antitrust Immunity
• Pursuing Wellness: Steps Toward A Supportive Firm Culture
• Zocdoc Strikes $1.4M Deal In Sales Workers' OT Suit
• J&J Beats Bias Suit From Woman Who Sought Exec Position
• Ohio Hospital Beats DaVita's Dialysis Coverage Suit
• Mass. Top Court Denies Hospital's Anti-SLAPP Appeal Again
• EEOC Nets Nearly $1M In Wave Of Disability Bias Deals
• Tower Health, Drexel To Buy Bankrupt Hospital For $50M
• Leading House Dem Wants Drug 'Hopping' Banned
• J&J's Litigation Bravado In Sharp Relief After Epic Opioid Trial
• Buyers Win Class Cert. In Blood Clot Drug Monopoly Suit
• Nurse's Hospital Retaliation Suit Nixed By Ky. Appeals Court
• SEC Says Ill. Rabbi Conned Jewish Community Out Of Millions
• Pursuing Wellness: Mental Health Education As A Firm Priority
• Judge Sinks Most Of Maritime Law Firm's Suit Against BCBS
• GAO Report Illuminates Insurer Influence On Drug Discounts
• Ethicon Wants Court To Drop Pittsburgh Pelvic Mesh Suit
• FDCA Doesn't Apply To Convicted NECC Workers, Judge Told
• Taxation With Representation: Simpson, Latham, Baker
• Drug Suppliers Admit To UK Market Fixing, Watchdog Says
• Jury's Task In Ohio Opioid MDL Trial Divides Drug Cos.
• Roundup, Essure Suits On A Collision Course, Judge Worries
• Cynosure Says Mass. Law Allows No 'Re-Do' Of False Ad Suit
• DOJ Allowed Into 7th Circ. Arguments On Syringe Price-Fixing
• Dem, GOP Lawmakers Ask FDA To Clear Path For CBD Retail
• J&J, Expert Debate If Asbestos In Talc Is 'Urban Legend'
• USCIS Will Process Deferred Action Bids Again After Backlash
• CORRECTED: 11th Circ. Says Cigna Can Enforce $25M Deal
• Pharmacy, PE Fund Ink $21M Deal To End FCA Kickback Suit
• TridentUSA's $9.5M Medicare Scheme Settlement Gets OK
• Purdue Files Ch. 11 Suit Seeking Stay Of Opioid Litigation
• Ex-Pharmacy Head Gets 33 Months In Misdosed Drugs Case
• Cooley-Led Datadog Leads 3 Cos. With Bullish $648M IPO
• Pursuing Wellness: A Firm's Work With Mental Health Experts
• NY Pharmacist Denies Oxycodone Conspiracy Charge
• House Democrats Unveil Drug Pricing Bill Opposed By GOP
• Catholic Hospital Must Face Transgender Man's Bias Suit
• Purdue Loses Bid To Toss Mass. Suit Amid Ch. 11 Stay Fight
• FDA Launches Criminal Probe Into Vaping Deaths, Illnesses
• Insys Ch. 11 Sale Of Controversial Drug OK'd With New Limits
• 9th Circ. Won't Revive Suit Over Army's Youth Diabetes Care
• Woman's J&J Talc Bottle Contained Asbestos, Expert Says
• 11th Circ. Says Feds Can Sue Under Title II Of ADA
• Health Co. Lied To Close Ill. Hospital For Assets, Suit Says
• FCC Links Lifeline, Medicaid Program Enrollment
• Ill. Court Upholds Zero Damages Award In Allergy Mix-Up Trial
• Novartis Halts Zantac Distribution, Citing Impurities
• TridentUSA Ch. 11 Plan Wins Court Approval
• W. Va. Hits J&J, Ethicon With Pelvic Mesh Suit
• Pursuing Wellness: When A Firm Brings Counseling On Site
• Skadden-Led Envista Tops 2 Health Care IPOs Totaling $764M
• Illinois Retirees Can't Get Health Premium Claims Revived
• Insurer Claims-Adjustment Documents Are Often Discoverable
• Outsourcing Facilities Face Rising Drug Compounding Risks
• Hong Leong, TPG Pay $1.2B For Hospitals In Southeast Asia
• Opioid 'Negotiation Class' Justifies DQ Bid, Distributors Say
• White House Dem Hopefuls Raise Pharma Deal Worries
• Henry Schein Case Illuminates Maze Of Arbitrability Questions
• Pharma Giants Can't Shake Ariz. Hospital's Opioid RICO Suit
• Hospitals Win Challenge To $600M Medicare Pay Cut
• Purdue Says 'Lives, Dollars' At Stake In Bankruptcy Case
• Couple Stole Key Research From Hospital, Feds Say
• McConnell Wants CBD Enforcement Guidelines, Now
• 3rd Circ. Revives FCA Suit Over UPMC Neurosurgery Referrals
• Health Orgs, Nonprofits Can't Join Public Charge Lawsuits Yet
• Pursuing Wellness: Inside A Firm Meditation Program
• Charity Execs Settle SEC Claims They Cheated Dying Patients
• Merck Trade Secret Suit A Ploy To Aid Patent Case, Pfizer Says
• Ill. Hospital Workers Win Cert. In Overtime Suit
• Calif. Guidelines Advance Telehealth For Medicaid Patients
• Weil Was Upfront About Repping Insys In Ch. 11, Atty Says
• Warby Parker Gets PTAB To Nix Obvious Eye Care Patent
• Chancery Keeps UnitedHealth Group Records Case Alive
• Aetna, OptumHealth Beat ERISA Suit Over Administrative Fees
• 4 Key Takeaways As Opioid MDL Distributors Seek Judge's DQ
• 'Big 3' Conspiracy Trial Against Benco Dental Supply Kicks Off
• Fla. House Can Wade Into Medical Pot Law Case, Panel Says
• Scientist Tells Calif. Court J&J Mesh Doesn't Degrade
• Top 5 Modern Tax Challenges For Digital Health Companies
• Trump's 'Public Charge' Rule Faces 1st Individual Challenge
• Generic Cos. Pan 'Irrelevant' Doc Demands In Price-Fix Case
• Hospital Network Gets Go-Ahead To End EEOC Disability Suit
• FCC Rural Health Developments Shift Focus To Functionality
• Early Sampling Of Electronic Info Is Underutilized In Discovery
• Momenta, Sandoz Push For Sanctions In Blood Clot Drug Suit
• Ex-Texas Hospital Exec Gets 10 Years In $16M Medicare Fraud
• Sentry Data, CVS Reach Deal In Antitrust Fight
• Opioid MDL Cos. Accused Of 'Inventing' Comments By Judge
• Court Is Wrong Place For Monopoly Case, E-Scrip Co. Says
• Teva Wants Pa. Investor Suit To Join Others In Conn.
• Purdue Pharma Seeks To Halt Opioid Suits With Ch. 11 Filing
• Opioid MDL Judge Deserves DQ For Bias, Distributors Say
• Norwegian Settles Teen Passenger's Medical Negligence Claim
• Union Wins Strikedown Of 2 Benefit Plan Terms In ERISA Row
• Jones Day Attys 'Very Much Regret' Grand Jury Redaction Slip
• Cos. Reach $9.5M Deal For Selling Non-FDA Cleared Devices
• Texas Panel OKs Nix Of Patient Death Suit For Faulty Notice
• 6th Circ. Serves Steak 'N Shake A Victory In COBRA Suit
• Ex-Cloud Co. Execs Lose Bid For Lifetime Medical Benefits
• Taxation With Representation: Wachtell, McDermott, Latham
• DOJ Asks To Argue In Health Cos.' Syringe Price-Fix Appeal
• Medicaid Fraud Claims Against Bon Secours Trimmed
• EEOC Roundup: Epilepsy Bias Suits, Rehab Center Settlement
• 6 Firms To Steer Health Care, Tech IPOs Set To Raise $1.5B
• AbbVie Investors Ask To Drop Ill. Humira Kickback Suit
• Rakoff Scolds Gov't, Sets Life Spine Kickback Trial For 2020
• Purdue's Sacklers Shifted $1B Amid Opioid Fight, NY AG Says
• Racketeering Claim Axed In $9M Hospital Overbilling Suit
• To Defer Or Not To Defer: Kisor's Impact On Tax Controversies
• Liberty Mutual Defeats Pharmacy's Painkiller Cream Suit
• Meet The Attys Leading The Opioid MDL 'Negotiation Class'
• 11th Circ. Backs Massage Envy In EEOC Suit Over Ebola Risk
• Denial Of Autism Care Coverage Violates ERISA, Parents Say
• Quest Cleared In Cedars-Sinai Trade Secrets Row
• The Factors Courts Consider In Deposition Location Disputes
• Health Hires: Alston Bird, Goodwin, Xencor
• Texas Ambulance Co. Must Face Suit Over Crash Injury
• 11th Circ. Overturns Class Cert. In PIP Reimbursement Row
• Purdue Bankruptcy May Leave State AGs Out In The Cold
• NLRB Memo Tackles Nursing Facility's Social Media Rules
• 'Petty Slights' Not Enough To Keep Mt. Sinai Bias Suit Alive
• 3rd Circ. Says No Hearing Guarantee For FCA Suit Dismissal
• 5th Circ. Says ERISA Trumps Tenn. Medical Bill Dispute Law
• Female Doctors' Pay Suit Decertified, But Heading To Trial
• Vanda Pharma Investor Accuses Brass Of Off-Label Marketing
• DOJ, FTC Bite Into Ala. Dental Board's 11th Circ. Appeal
• Gov't Win In AseraCare FCA Case Benefits Both Sides
• Biopharma Co. Investors Allege Voting Rule Fouls In Del. Suit
• 9th Circ. Says ERISA Doesn't Preempt Hawaii Insurance Laws
• What To Consider Before Filing For A Rule 57 Speedy Hearing
• Esformes Gets 20 Years In Miami Health Care Fraud
• E-Cig Seller Hid SF Ban Ahead Of IPO, Investors Say
• Simpson Thacher Steers Genomics' $390M Upsized IPO
• Skadden-Led SmileDirectClub Prices $1.3B IPO Above Range
• Non-Atty Mother Can Rep Daughter In Fla. Medicaid Appeal
• Covington Nabs 11-Year Federal Prosecutor For NY Office
• Pa. Justice Questions Scope Of Mental Health Liability Waiver
• Del. Justices Press For More In Tossed Dilution Suit Appeal
• NY Hospital Must Face New Trial Over Man's Pneumonia Death
• Jones Day Needs Mea Culpa To Avoid Grand Jury Flub Fallout
• Senate Dems Seek To Tax E-Cigs At Same Rate As Tobacco
• 6th Circ. Won't Reinstate DQ'd BakerHostetler In Opioid MDL
• China Spares 16 US Goods From Duties Ahead Of Talks
• Opioid MDL 'Negotiation Class' Wins Approval
• Deals Rumor Mill: WeWork, Groupon, Grab Holdings
• Purdue To Settle Thousands Of Opioid Suits, File Bankruptcy
• Jones Day Faces Sanctions Threat After Redaction Flub
• 7th Circ. Probes Method Behind $31M Kidney Failure Verdict
• Reviewing Recent FDA Activity In Bulk Drugs Lists
• White House Prepares To Ban Flavored E-Cigs
• Jones Day Botches Grand Jury Redaction In Attack On DOJ
• FDA Faces Free Speech Issues With Juul Warnings
• CVS To Pay $4.4M For Divulging HIV Status Of 6,000 Patients
• Canadian Cannabis Biz Hit With Investor Suit Over $143M IPO
• Feds Seek 30 Years For Nursing Home Mogul Esformes
• CVS-Aetna Deal Clouds Merger Reviews, DOJ Deputy Says
• J&J Says Science Backs Its Talc At Opening Of Calif. Retrial
• Organon Whistleblowers Acted As Law Expects, 1st Circ. Says
• Gov't Sued Over Premature Baby's Death At IHS Hospital
• IHS Nabs Early Victory In Wash. Tribe's Contract Costs Suit
• Moms Retry Class Cert. In UnitedHealth Breastfeeding Suit
• What CMS Rule On Affiliations Means For Health Providers
• ND 'Abortion Reversal' Law 'Arguably Unethical,' Judge Says
• FTC Warns 3 CBD Sellers About Bogus Health Claims
• Workers' Challenge Of 401(k) Fees Time-Barred, BTG Says
• Weil Downplayed Atty Conflict, Convicted Insys Exec Says
• Simpson Thacher-Led Genomics Co. Ups IPO Target To $342M
• Yale Case Reminds Employers Of Key Wellness Program Risk
• Why I Became A Lawyer: Expanding The Meaning Of Diversity
• Purdue, Opioid Distributors Can't Dodge RICO Claims In MDL
• Del. Judge 'Unlikely' To Halt True Health Medicare Payments
• Mallinckrodt To Sell BioVectra To HIG For Up To $250M
• Pa. Court Revives Suit Over Man's Foot Amputation Injury
• Feds Ask To Delay Proposed Subsys Sale
• 4th Circ. Won't Rehear Nixed $7.1M Baby Injury Award
• HHS Reaches 1st-Of-A-Kind Settlement Over Patient Records
• Texas County Mulls Hospital, Emergency Services Tax Hikes
• 13 States Urge 6th Circ. To Block Ohio Opioid Bellwether
• Boston Properties Nabs Suburban Mass. Offices For $106M
• $10M Award May 'Raise Stakes' For Firing Mass. Profs
• Datadog Leads IPO Flurry Expected To Raise $729M Combined
• 11th Circ. Revives AseraCare FCA Saga In Win For DOJ
• Juul Illegally Marketed E-Cigs As Safe To Youths, FDA Says
• Law360 Names Top Attorneys Under 40
• Congress Pressed To Renew Funding For Rape Kit Testing
• Fed. Circ. Clouds Landscape For Medical Treatment Patents
• EEOC Roundup: U Of Kansas, Hitachi Among Latest Targets
• Feds Say Esformes Must Forfeit $38.7M In Laundering Case
• Shkreli Claims Ex-Investor's Son Duped Him Into Debt Note
• Biopharma Co. Regulus Dodges Stock Suit Over Drug Trials
• Exec Accused As Part Of $1.2B Fraud Scam Enters Guilty Plea
• Edibles Co. Sees TM Claims Tossed Over Pot's Illegal Status
• Lone Star Laterals: Skadden, Haynes and Boone, Locke Lord
• 9 Firms To Guide 6 IPOs Eyeing Nearly $2.2B To Start Sept.
• Health Care Providers Say HHS Rule Is Based On A 'Lie'
• Hospitals' Suit Over Anesthesiologist Noncompetes Nixed
• Pa. Contract Binding On Part-Owners Of Indian Cricket Team
• Zicam Maker Hit With Patent Suit Over Nasal Spray Formula
• A Win For Fla. Hospitals On Patient Safety Data Confidentiality
• Mallinckrodt Pays $24M To Exit Opioid MDL Bellwethers
• Why Opioid Suits Avoid GCs — And Why That Could Change
• Discovery Counsel Vital In All Phases Of Mass Tort Litigation
• Fed. Circ. Probes If Galderma Bound By Statements To PTAB
• DOJ Charges 30 In Bay Area Medicare Kickback Scheme
• HHS Can Revisit Hospital Pay Despite 15-Year Fight: Judge
• 4 Key Takeaways As Ohio AG Fires Torpedo At Opioid MDL
• CVS-Aetna Review Ends In Parting Shots & Punctuation!
• SmileDirectClub Frowns On Dentists' Bid For 11th Circ. Appeal
• Insurer, Behavioral Health Co. Sued Over Live-In Treatment
• Gov't Hit With Suit Over Deferred Action Program
• Mallinckrodt Pays $15M In 'Wine And Dine' FCA Case
• Philly Hospital's $55M Doctor-Program Sale Approved
• How The Wayback Machine Can Strengthen Your Case
• Bellus Health Raises $70M In Upsized Stateside IPO
• Class Attys Nab $8.4M Cut Of $24M Anthem 401(k) Settlement
• MSU To Pay Record $4.5M Fine For Nassar Sex Abuse Scandal
• Philip Morris Tells Mass. Jury Woman's Smoking Was Choice
• Pa. Hospital, Doc Not Liable For Infant's Death, Jury Finds
• Cedars-Sinai Doc Toiled 15 Years To Invent IBS Test, Jury Told
• Whether Opioid Crisis Is 'Public Nuisance' Up To Jury: Judge
• Hospital Owner Says Training Program Sale Needs To Happen
• Gilead Says HIV 'No Generic' Suit Is Baseless
• Former FDA Head Can Testify In Sanofi Hair Loss Trial
• Watchdog Urges Gov't To Improve Migrant Kids' Mental Health
• Nursing Homes Lodge Fresh Attack On CMS Arbitration Limits
• CVS-Aetna Merger Cleared After Unprecedented Court Battle
• Psychiatrist Retaliated After Legal Threat, 1st Circ. Told
• Skadden Steers Danaher Dental Unit's Potential $600M IPO
• Mississippi's Mental Health System Violates ADA, Judge Says
• Risks To Avoid When Conducting Virtual Clinical Trials
• Mail-Order Fecal Analysis Startup Files For Bankruptcy
• Draft Civil Procedure Jurisdictional Rule Needs A Tweak
• VillageMD Nabs $100 Million in Kinnevik-Led Series B Round
• Atlantic Street Taps Morrison Cohen For $500M PE Fund
• Pa. Justices To Mull UPMC Docs' Liability In Mass Shooting
• University Of Calif. Must Face Suit Over Unborn Twins' Deaths
• Opioid MDL Jury Will Weigh 'Complete Failures' By Drug Cos.
• CVS Mad About Findings, Not Discovery Pace, Sentry Says
• USCIS Reopens Deferred Action Requests After Outcry
• Quest Diagnostics Can't Use High Court To Evade TCPA Case
• $12B ACA About-Face Unprecedented, Insurers Tell Justices
• Real Estate Rumors: Brodsky, Natixis, Neiman Marcus
• Pharma Deal Made Monopoly For Diabetes Drug, Buyer Says
• 5 Health Care IPOs Could Total $682M, Led By Genomics Biz
• Skadden-Led Orthodontics Biz Launches Potential $1.2B IPO
• How DHS' Public Charge Rule Will Affect Immigrant Benefits
• Atrium Defeats Suit, Convincing Judge It's ERISA-Exempt
• Bankrupt Insys Plans Fentanyl Spray Sale To Competitor